Home » Topics » BioWorld Science

BioWorld Science
RSS

New 5-HT1D antagonists from Pierre Fabre

April 26, 1996

SKB reports 5-HT2B/2C antagonists for CNS indications

April 26, 1996

Visipaque approved for marketing in U.S.

April 26, 1996

OraScan 100% sensitive in detecting oral squamous cell carcinomas

April 26, 1996

ISV-900 for diagnosis of glaucoma

April 26, 1996

Trinity Biotech begins marketing osteoporosis test in selected markets

April 26, 1996

Metasyn updates on MS-325 progress

April 26, 1996

AntiCancer's HDRA receives patent protection

April 26, 1996

Athena receives patent protection for ApoE in diagnosis of AD

April 26, 1996

Neoprobe, Peptor to codevelop peptide analogues for cancer diagnosis & treatment

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...